Literature DB >> 1883345

Relationship between the neural dysgenesis and increased production of class I MHC H-2Kk mRNA and protein in neurons of murine trisomy 16 fetuses.

S Kornguth1, K J Mack, E Bersu.   

Abstract

Neuronal cells from murine trisomy 16 fetuses have increased levels of class I MHC H-2Kk. To determine whether this increased level of H-2Kk protein product resulted from an increased synthesis of mRNA, a 33 base antisense cDNA probe complementary to a region in exon 2 of the H-2Kk sequence (nucleotide 392-424) was synthesized. This probe was used to examine, by in situ hybridization and immunohistochemistry, the neural distribution of H-2Kk mRNA and protein product. A marked elevation of the H-2Kk mRNA and protein were localized in mts16 neuronal populations that were susceptible to dysgenesis. The results implicate the expression of the H-2Kk in the neuropathology of mts16 and its human counterpart, Down syndrome.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1883345     DOI: 10.1016/0006-291x(91)91340-i

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Cutting edge: MHC class I-Ly49 interaction regulates neuronal function.

Authors:  Ofer Zohar; Yoram Reiter; Jack R Bennink; Avital Lev; Sebastiano Cavallaro; Sabrina Paratore; Chaim G Pick; Gary Brooker; Jonathan W Yewdell
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422

2.  A Proposed Mechanism for Development of CTE Following Concussive Events: Head Impact, Water Hammer Injury, Neurofilament Release, and Autoimmune Processes.

Authors:  Steven Kornguth; Neal Rutledge; Gabe Perlaza; James Bray; Allen Hardin
Journal:  Brain Sci       Date:  2017-12-19

Review 3.  Integration of Biomarkers Into a Signature Profile of Persistent Traumatic Brain Injury Involving Autoimmune Processes Following Water Hammer Injury From Repetitive Head Impacts.

Authors:  Steven Kornguth; Neal Rutledge
Journal:  Biomark Insights       Date:  2018-10-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.